VACV-ITGA9 mab (2U5SI1Q1Q) WT Cas9-ASGR1 for B Cell Engineering (CAT#: BGS-0524-CR144)

The product is a highly efficient, inducible WT Cas9-ASGR1 gene-editing based novel VACV packaging system that can be used to mediate researches involving anti-ITGA9 mab (2U5SI1Q1Q) in Murine B cell engineering.

Datasheet

Specifications

Clone 2U5SI1Q1Q
Host Humanized
Packaging Cell Line CHO-S
Vector Promoter EF1a
Rep Rep68
Capsid P24
Envelope VSV-G
Matrix N-terminal
Size ~24kb
Genome dsDNA
Virus Type VACV
Cofactor Requirement No ATP, CP, or CPK
Particles/mL 1.9 × 10¹¹
PFU/mL 1.2 × 10¹¹
TU/mL 5.6 × 10¹¹
Cas9 WT Cas9
sgRNA ASGR1
Engineered B Cell Murine B cells

Target Information

Target ITGA9
Alternative Names ITGA9; integrin; alpha 9; RLC; ITGA4L; ALPHA-RLC; integrin alpha-9; integrin alpha-RLC
Gene ID 3680(Human); 104099(Mouse); 685004(Rat)
UniProt ID Q13797(Human)

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products